Tolerability of concurrent external beam radiotherapy and [177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)

Tolerability of concurrent external beam radiotherapy and [177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)

Abstract Background Prostate cancer patients with locoregional lymph node disease at diagnosis (N1M0) still have a limited prognosis despite the improvements provided by aggressive curative intent multimodal locoregional external beam radiation therapy (EBRT) with systemic androgen deprivation thera...

Full description

Bibliographic Details
Main Authors: Esmée C. A. van der Sar, Arthur J. A. T. Braat, Jochem R. N. van der Voort- van Zyp, Betty S. van der Veen, Pim J. van Leeuwen, Daphne M. V. de Vries-Huizing, Jeroen M. A. Hendrikx, Marnix G. E. H. Lam, Wouter V. Vogel
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Cancer
Subjects:
Lu-PSMA
Prostate cancer
Node-positive
Online Access:https://doi.org/10.1186/s12885-023-10725-5

Internet

https://doi.org/10.1186/s12885-023-10725-5

Similar Items